Link to this page
Medical Subject Headings
| Preferred Name | Alemtuzumab | |
| Synonyms |
MabCambath Campath 1G Campath1G Monoclonal Antibody Campath 1H Lemtrada Campath-1G Campath 1H Campath-1-G Monoclonal Antibody Campath-1H Campath-1H, Monoclonal Antibody Campath Campath1H Campath 1M Campath 1 G Campath-1H Antibody Campath-1H, Monoclonal Campath-1M |
|
| Definitions |
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000074323 |
|
| altLabel |
MabCambath Campath 1G Campath1G Monoclonal Antibody Campath 1H Lemtrada Campath-1G Campath 1H Campath-1-G Monoclonal Antibody Campath-1H Campath-1H, Monoclonal Antibody Campath Campath1H Campath 1M Campath 1 G Campath-1H Antibody Campath-1H, Monoclonal Campath-1M
|
|
| AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
|
|
| cui |
C1178562 C0939276 C0667141 C0383429 C0289523 C3860145 C1529566
|
|
| DC |
1
|
|
| definition |
An anti-CD52 ANTIGEN monoclonal antibody used for the treatment of certain types of CD52-positive lymphomas (e.g., CHRONIC LYMPHOCYTIC LEUKEMIA; CUTANEOUS T-CELL LYMPHOMA; and T-CELL LYMPHOMA). Its mode of actions include ANTIBODY-DEPENDENT CELL CYTOTOXICITY.
|
|
| DX |
20180101
|
|
| FX |
D000074301
|
|
| HN |
2018 (1995)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000096 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000648 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000502 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000187 http://purl.bioontology.org/ontology/MESH/Q000235 http://purl.bioontology.org/ontology/MESH/Q000633 |
|
| Inverse of RB |
3A189DH42V 0
|
|
| Inverse of RO | ||
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2018; ALEMTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, 1995-2011 and under ANTIBODIES, MONOCLONAL, HUMANIZED, 2012-2017
|
|
| MDA |
20170711
|
|
| MMR |
20170410
|
|
| MN |
D12.776.124.486.485.114.224.060.313 D12.776.124.790.651.114.224.060.375 D12.776.377.715.548.114.224.200.375
|
|
| notation |
D000074323
|
|
| PA |
D000074322
|
|
| prefLabel |
Alemtuzumab
|
|
| TERMUI |
T000915126 T621979 T312464 T267463 T534884 T267464 T267462 T312465 T283973 T283971 T000915098 T000915099
|
|
| TH |
NLM (1997) NLM (2004) NLM (1995) NLM (2005) NLM (1994) NLM (2018)
|
|
| tui |
T109 T116 T129 T130 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |